cefepime has been researched along with Fasciitis--Necrotizing* in 2 studies
2 other study(ies) available for cefepime and Fasciitis--Necrotizing
| Article | Year |
|---|---|
Successful conservative treatment of necrotizing fasciitis associated with Aeromonas veronii in a patient with acute myeloid leukemia.
Topics: Aeromonas veronii; Aged; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Combined Modality Therapy; Conservative Treatment; Consolidation Chemotherapy; Debridement; Drug Therapy, Combination; Fasciitis, Necrotizing; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Male; Treatment Outcome | 2020 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
We present a diabetic patient with necrotizing fasciitis caused by Citrobacter freundii associated with an injury from the fish fin. Two isolates recovered six days after cefotaxime treatment had a cefotaxime minimum inhibitory concentration (MIC) of 0.12 and 256 mg/L, respectively, and a cefepime MIC of 0.03 and 0.25 mg/L, respectively. The two isolates both possessed bla(CMY-2) gene. The patient responded unsatisfactorily to cefotaxime and cefepime therapy and surgical debridement but recovered completely after ertapenem treatment for 42 days. Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |